Stockholders' Equity (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Stockholders' Equity Note [Abstract] |
|
| Schedule of Common Stock |
In the three and six months ended June 30, 2026 and 2025, no shares of Class B common stock were converted to Class A common stock. As of June 30, 2026, the par value of the Class A, Class B and Class C shares was $153, $14, and $3, respectively. As of December 31, 2025 the aggregate par value of the Class A, Class B and Class C shares was $148, $14 and $3, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
December 31, 2025 |
|
|
|
Shares Authorized |
|
|
Shares Issued and Outstanding |
|
|
Shares Issued and Outstanding |
|
Class A |
|
|
1,000,000,000 |
|
|
|
15,277,711 |
|
|
|
14,782,788 |
|
Class B |
|
|
100,000,000 |
|
|
|
1,369,518 |
|
|
|
1,369,518 |
|
Class C |
|
|
200,000,000 |
|
|
|
277,777 |
|
|
|
277,777 |
|
|
|
|
1,300,000,000 |
|
|
|
16,925,006 |
|
|
|
16,430,083 |
|
|
| Activity under Plans |
Activity under the Plans is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
|
Weighted
Average
Exercise Price |
|
|
Weighted Average
Remaining
Contractual
Term (Years) |
|
|
Aggregate
Intrinsic Value |
|
Outstanding as of January 1, 2026 |
|
|
340,426 |
|
|
$ |
107.43 |
|
|
|
2.9 |
|
|
$ |
— |
|
Forfeited |
|
|
(34,700 |
) |
|
|
110.12 |
|
|
|
|
|
|
|
Expired |
|
|
(9,015 |
) |
|
|
49.40 |
|
|
|
|
|
|
|
Outstanding as of June 30, 2026 |
|
|
296,711 |
|
|
$ |
108.88 |
|
|
|
2.4 |
|
|
$ |
— |
|
Vested and expected to vest as of December 31, 2025 |
|
|
340,206 |
|
|
$ |
107.43 |
|
|
|
2.9 |
|
|
$ |
— |
|
Vested and expected to vest as of June 30, 2026 |
|
|
296,491 |
|
|
$ |
108.87 |
|
|
|
2.4 |
|
|
$ |
— |
|
Options exercisable as of December 31, 2025 |
|
|
340,426 |
|
|
$ |
107.43 |
|
|
|
2.9 |
|
|
$ |
— |
|
Options exercisable as of June 30, 2026 |
|
|
296,711 |
|
|
$ |
108.88 |
|
|
|
2.4 |
|
|
$ |
— |
|
|
| Summary of Unvested Restricted Stock Unit Activity |
Activity for the restricted stock units is as follows:
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Weighted Average
Grant Date
Fair Value |
|
Unvested as of January 1, 2026 |
|
|
1,194,219 |
|
|
$ |
14.91 |
|
Granted |
|
|
529,971 |
|
|
|
5.79 |
|
Vested |
|
|
(433,175 |
) |
|
|
16.14 |
|
Forfeited |
|
|
(98,499 |
) |
|
|
15.20 |
|
Unvested as of June 30, 2026 |
|
|
1,192,516 |
|
|
$ |
10.39 |
|
|
| Summary of Performance-based or Market Condition Share Awards |
Activity for the restricted stock units with a performance or market condition is as follows:
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Weighted Average
Grant Date
Fair Value |
|
Unvested as of January 1, 2026 |
|
|
229,579 |
|
|
$ |
11.79 |
|
Cancelled/Forfeited |
|
|
(71,810 |
) |
|
|
9.69 |
|
Expired |
|
|
(24,436 |
) |
|
|
43.73 |
|
Unvested as of June 30, 2026 |
|
|
133,333 |
|
|
$ |
7.06 |
|
|
| Stock-Based Compensation Expense |
Stock-based compensation expense, related to all of the Company's stock-based awards, was classified in the condensed consolidated statements of operations and comprehensive loss as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Cost of revenues |
|
$ |
70 |
|
|
$ |
200 |
|
|
$ |
187 |
|
|
$ |
463 |
|
Research and development |
|
|
623 |
|
|
|
1,551 |
|
|
|
1,496 |
|
|
|
3,161 |
|
Selling and marketing |
|
|
264 |
|
|
|
557 |
|
|
|
533 |
|
|
|
1,164 |
|
General and administrative |
|
|
1,071 |
|
|
|
3,354 |
|
|
|
2,116 |
|
|
|
8,560 |
|
Total |
|
$ |
2,028 |
|
|
$ |
5,662 |
|
|
$ |
4,332 |
|
|
$ |
13,348 |
|
|